News & Updates
Filter by Specialty:
Singapore-specific myocardial infarction risk score goes toe-to-toe with international tools
A myocardial infarction (MI) risk score derived from the Singapore Myocardial Infarction Registry (SMIR) performs just as well as international standards, such as the refined Global Registry of Acute Coronary Events (GRACE 2.0) score, according to a recent study.
Singapore-specific myocardial infarction risk score goes toe-to-toe with international tools
02 Sep 2022
Increased potassium intake vital for heart health in women
In the EPIC-Norfolk* study, a sex-specific association was found between daily potassium intake, systolic blood pressure (SBP), and cardiovascular disease (CVD). The findings particularly suggest that in women with high sodium intake, higher potassium intake was tied to lower SBP.
Increased potassium intake vital for heart health in women
01 Sep 2022
Higher dietary glycaemic index, load up CVD mortality risk
A dietary pattern with increased glycaemic index (GI) and load (GL) appears to elevate the risk of death due to cardiovascular diseases (CVDs), suggests a study involving Chinese adults.
Higher dietary glycaemic index, load up CVD mortality risk
31 Aug 2022
No clear link between atopic dermatitis and venous thromboembolism
There appears to be no evidence that atopic dermatitis or treatment with Janus kinase (JAK) inhibitors carries an increased risk of venous thromboembolism, according to a study.
No clear link between atopic dermatitis and venous thromboembolism
30 Aug 2022
RYGB in severe obesity leads to weight loss, hypertension remission
In patients with severe obesity, undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (RYGB) resulted in weight loss, according to long-term follow-up of the SLEEVEPASS* trial. However, remission of hypertension was more likely in patients who underwent RYGB compared with LSG.
RYGB in severe obesity leads to weight loss, hypertension remission
29 Aug 2022
Combined oral contraceptives and VTE: Which pill conveys the highest risk in young women?
Combined oral contraceptives (COCs) that contain gestodene confer a fivefold increased risk of venous thromboembolism (VTE) in young women as compared with those that contain levonorgestrel and the lowest doses of ethinylestradiol, as shown in a study.